# Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria

> **NCT02935699** · PHASE3 · COMPLETED · sponsor: **JDP Therapeutics, Inc.** · enrollment: 262 (actual)

## Conditions studied

- Acute Urticaria

## Interventions

- **DRUG:** Test Drug (JDP-205)
- **DRUG:** Active Control (Diphenhydramine)

## Key facts

- **NCT ID:** NCT02935699
- **Lead sponsor:** JDP Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2018-04-30
- **Final completion:** 2018-04-30
- **Target enrollment:** 262 (ACTUAL)
- **Last updated:** 2019-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02935699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02935699, "Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02935699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*